These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17534677)

  • 21. Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysis.
    De la Calle C; Ternavasio-de la Vega HG; Morata L; Marco F; Cardozo C; García-Vidal C; Del Rio A; Cilloniz C; Torres A; Martínez JA; Mensa J; Soriano A
    J Infect; 2018 Apr; 76(4):342-347. PubMed ID: 29360520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe pneumonia and a second antibiotic.
    Macfarlane J
    Lancet; 2002 Apr; 359(9313):1170-2. PubMed ID: 11955532
    [No Abstract]   [Full Text] [Related]  

  • 23. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
    Mufson MA; Chan G; Stanek RJ
    Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of hospitalized patients with bacteraemic and non-bacteraemic community-acquired pneumonia caused by Streptococcus pneumoniae.
    Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
    Epidemiol Infect; 2011 Sep; 139(9):1307-16. PubMed ID: 20974020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prognostic factors and mortality in immunocompetent adult patients hospitalized with community-acquired pneumococcal pneumonia].
    Saldías P F; Viviani G P; Pulgar B D; Valenzuela F F; Paredes E S; Díaz P O
    Rev Med Chil; 2009 Dec; 137(12):1545-52. PubMed ID: 20361129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteremic pneumococcal pneumonia in adults admitted to a general hospital. Experience in 60 cases].
    Rioseco Z ML; Riquelme O R; Riquelme O M; Inzunza P C; Riquelme D J; Sanhueza R A
    Rev Med Chil; 2018 Jul; 146(7):839-845. PubMed ID: 30534882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community-acquired bacteraemic pneumococcal pneumonia in adults: effect of diminished penicillin susceptibility on clinical outcome.
    Bonnard P; Lescure FX; Douadi Y; Schmit JL; Jounieaux V; Laurans G; Eb F; Ducroix JP
    J Infect; 2005 Jul; 51(1):69-76. PubMed ID: 15979494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC; Ioachimescu AG; Iannini PB
    Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic de-escalation therapy in patients with community-acquired nonbacteremic pneumococcal pneumonia.
    Uda A; Tokimatsu I; Koike C; Osawa K; Shigemura K; Kimura T; Miyara T; Yano I
    Int J Clin Pharm; 2019 Dec; 41(6):1611-1617. PubMed ID: 31654366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU.
    Moine P; Vercken JB; Chevret S; Gajdos P
    Scand J Infect Dis; 1995; 27(3):201-6. PubMed ID: 8539541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monotherapy versus combination antimicrobial therapy for pneumococcal pneumonia.
    Waterer GW
    Curr Opin Infect Dis; 2005 Apr; 18(2):157-63. PubMed ID: 15735421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in mortality in severe community-acquired pneumococcal pneumonia: impact of improving antibiotic strategies (2000-2013).
    Gattarello S; Borgatta B; Solé-Violán J; Vallés J; Vidaur L; Zaragoza R; Torres A; Rello J;
    Chest; 2014 Jul; 146(1):22-31. PubMed ID: 24371840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteremic pneumococcal pneumonia associated with macrolide failure.
    Dylewski J; Davidson R
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):39-42. PubMed ID: 16411124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical presentation, processes and outcomes of care for patients with pneumococcal pneumonia.
    Brandenburg JA; Marrie TJ; Coley CM; Singer DE; Obrosky DS; Kapoor WN; Fine MJ
    J Gen Intern Med; 2000 Sep; 15(9):638-46. PubMed ID: 11029678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Community-Acquired Pneumococcal Pneumonia in Virologically Suppressed HIV-Infected Adult Patients: A Matched Case-Control Study.
    Cillóniz C; Torres A; Manzardo C; Gabarrús A; Ambrosioni J; Salazar A; García F; Ceccato A; Mensa J; de la Bella Casa JP; Moreno A; Miró JM
    Chest; 2017 Aug; 152(2):295-303. PubMed ID: 28302496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials.
    Shorr AF; Kollef M; Eckburg PB; Llorens L; Friedland HD
    Diagn Microbiol Infect Dis; 2013 Mar; 75(3):298-303. PubMed ID: 23357290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Revisiting combination antibiotic therapy for community-acquired invasive Streptococcus pneumoniae pneumonia.
    Mufson MA; Stanek RJ
    Clin Infect Dis; 2006 Jan; 42(2):304-6. PubMed ID: 16355349
    [No Abstract]   [Full Text] [Related]  

  • 40. Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia.
    Martínez JA; Horcajada JP; Almela M; Marco F; Soriano A; García E; Marco MA; Torres A; Mensa J
    Clin Infect Dis; 2003 Feb; 36(4):389-95. PubMed ID: 12567294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.